- Home
- TDF vs SIGA Comparison
TDF vs SIGA Comparison
Compare TDF & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TDF | SIGA |
|---|---|---|
| Founded | 1994 | 1995 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.5M | 223.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | TDF | SIGA |
|---|---|---|
| Price | $8.96 | $3.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.1K | ★ 489.6K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | N/A | ★ 18.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $170.70 |
| P/E Ratio | ★ N/A | $24.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.86 | $2.83 |
| 52 Week High | $12.20 | $8.46 |
Technical Indicators
Market Signals| Indicator | TDF | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 24.37 | 42.96 |
| Support Level | N/A | $3.03 |
| Resistance Level | $11.31 | $3.32 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.55 | 13.68 |
Price Performance
Historical ComparisonAbout TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invest in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.